 REDWOOD CITY, Calif., Oct. 20, 2022 GLOBE NEWSWIRE -- Pulmonx Corporation Nasdaq: LUNG Pulmonx, a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2022 after the close of trading on Thursday, November 3, 2022. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT 4:30 p.m. ET. 